• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

WHO: Middle East respiratory syndrome coronavirus (MERS-CoV) ? Saudi Arabia (19 December 2016)

Shiloh

Editor, Senior Moderator
Source: http://www.who.int/csr/don/19-december-2016-2-mers-saudi-arabia/en/

[h=1]Middle East respiratory syndrome coronavirus (MERS-CoV) ? Saudi Arabia[/h] Disease outbreak news
19 December 2016

Between 6 and 13 December 2016 the National IHR Focal Point of Saudi Arabia reported ten (10) additional cases of Middle East Respiratory Syndrome (MERS) including two (2) fatal cases. Three (3) deaths among previously reported MERS cases were also reported.
[h=3]Details of the cases[/h]
  • A 72-year-old male national living in Taif city, Taif Region. He developed symptoms on 9 December and was admitted to hospital on 10 December. The patient who has comorbidities, tested positive for MERS-CoV on 12 December. He has a history of contact with camels and consumption of their raw milk in the 14 days prior to the onset of symptoms. Currently the patient is in critical condition admitted to ICU but not on mechanical ventilation. The Ministry of Agriculture has been informed and investigation of camels is ongoing.
  • A 64-year-old female national living in Buridah city, Qassim Region. She developed symptoms on 3 December and was admitted to hospital on 9 December. The patient who has comorbidities, tested positive for MERS-CoV on 10 December. Investigation of history of exposure to the known risk factors is ongoing. Currently the patient is in critical condition admitted to ICU on mechanical ventilation.
  • A 59-year-old male national living in Mahayl Assir city, Assir Region. He developed symptoms on 28 November and was admitted to hospital on 8 December. The patient who has no comorbidities, tested positive for MERS-CoV on 10 December. He has a history of contact with camels and consumption of their raw milk in the 14 days prior to the onset of symptoms. Currently the patient is in stable condition admitted to a negative pressure isolation room on a ward. The Ministry of Agriculture has been informed and investigation of camels is ongoing.
  • A 60-year-old male national living in Mahayl Assir city, Assir Region. He developed symptoms on 28 November and was admitted to hospital on 4 December. The patient who has comorbidities, tested positive for MERS-CoV on 6 December. He has a history of contact with camels and consumption of their raw milk in the 14 days prior to the onset of symptoms .The patient was in critical condition admitted to ICU on mechanical ventilation. He passed away on 6 December. The Ministry of Agriculture has been informed and investigation of camels is ongoing.
  • A 49-year-old male non-national living in Jeddah city, Jeddah Region. He developed on 30 November and was admitted to hospital on 6 December. The patient who has no comorbidities, tested positive for MERS-CoV on 7 December. The patient has no comorbid conditions. Investigation of history of exposure to the known risk factors is ongoing. Currently the patient is in stable condition admitted to a negative pressure isolation room on a ward.
  • A 53-year-old male non-national living in Riyadh city, Riyadh Region. He developed symptoms on 4 December and was admitted to hospital on 7 December. The patient who has no comorbidities, tested positive on 8 December. Investigation of history of exposure to the known risk factors is ongoing. Currently the patient is in critical condition admitted to ICU on mechanical ventilation.
  • A 56-year-old male national living in Riyadh city, Riyadh Region. He developed symptoms on 3 December and was admitted to hospital on 6 December. The patient who has comorbidities, tested positive for MERS-CoV on 7 December. Investigation of history of exposure to the known risk factors is ongoing. The patient was in stable condition admitted to a negative pressure isolation room on a ward. His conditions deteriorated and he passed away on 10 December.
  • A 24-year-old male national living in Hofouf city, Al Ahssa Region. He developed symptoms on 24 November and was admitted to hospital on 3 December. The patient who has no comorbidities, tested positive for MERS-CoV on 5 December. Investigation of history of exposure to the known risk factors is ongoing. Currently the patient is in stable condition admitted to a negative pressure isolation room on a ward.
  • A 78-year-old male national living in Riyadh city, Riyadh Region. He developed symptoms on 27 November and was admitted to hospital on 3 December. The patient who has comorbidities, tested positive for MERS-CoV on 5 December. Investigation of history of exposure to the known risk factors is ongoing. Currently the patient is in stable condition admitted to a negative pressure isolation room on a ward.
  • A 58-year-old male national living in Afif city, Riyadh Region. He developed symptoms on 3 December and was admitted to hospital on 4 December. The patient who has no comorbidities, tested positive for MERS-CoV on 5 December. Investigation of history of exposure to the known risk factors is ongoing. Currently the patient is in stable condition admitted to a negative pressure isolation room on a ward.
Contact tracing of household and healthcare contacts is ongoing for these cases.
The National IHR Focal Point for the Kingdom of Saudi Arabia also notified WHO of the deaths of 3 MERS-CoV cases that were reported in a previous DON published on 19 December 2016 (case numbers 4, 5, and 9).
Globally, since September 2012, WHO has been notified of 1864 laboratory-confirmed cases of infection with MERS-CoV including at least 659 related deaths.
[h=3]WHO risk assessment[/h] MERS-CoV causes severe human infections resulting in high mortality and has demonstrated the ability to transmit between humans. So far, the observed human-to-human transmission has occurred mainly in health care settings.
The notification of additional cases does not change the overall risk assessment. WHO expects that additional cases of MERS-CoV infection will be reported from the Middle East, and that cases will continue to be exported to other countries by individuals who might acquire the infection after exposure to animals or animal products (for example, following contact with dromedaries) or human source (for example, in a health care setting). WHO continues to monitor the epidemiological situation and conducts risk assessment based on the latest available information.
[h=3]WHO advice[/h] Based on the current situation and available information, WHO encourages all Member States to continue their surveillance for acute respiratory infections and to carefully review any unusual patterns.
Infection prevention and control measures are critical to prevent the possible spread of MERS-CoV in health care facilities. It is not always possible to identify patients with MERS-CoV early because like other respiratory infections, the early symptoms of MERS-CoV are non-specific. Therefore, health-care workers should always apply standard precautions consistently with all patients, regardless of their diagnosis. Droplet precautions should be added to the standard precautions when providing care to patients with symptoms of acute respiratory infection; contact precautions and eye protection should be added when caring for probable or confirmed cases of MERS-CoV infection; airborne precautions should be applied when performing aerosol generating procedures.
Until more is understood about MERS-CoV, people with diabetes, renal failure, chronic lung disease, and immunocompromised persons are considered to be at high risk of severe disease from MERS-CoV infection. Therefore, these people should avoid close contact with animals, particularly camels, when visiting farms, markets, or barn areas where the virus is known to be potentially circulating. General hygiene measures, such as regular hand washing before and after touching animals and avoiding contact with sick animals, should be adhered to.
Food hygiene practices should be observed. People should avoid drinking raw camel milk or camel urine, or eating meat that has not been properly cooked.
WHO does not advise special screening at points of entry with regard to this event nor does it currently recommend the application of any travel or trade restrictions.


AddThis Sharing Buttons Share to Print
Share to Email

Share to Facebook
Share to Twitter
Share to Google+
Share to More




[h=3]Related links[/h]
 
Back
Top